Search

RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions
Inflation Reduction Act (IRA) University
Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management
The Accelerated Approval Program: Balancing Crucial Patient Access with Timely Evidentiary Needs
Precision Medicine in Practice: Aligning Standards, Advocacy, and Coverage
Driving Quality in Oncology Medication Use Through Precision Medicine
Patient Experience Data in Managed Care Pharmacy Decision Making; Barriers, Opportunities, and Practical Strategies for Managed Care Pharmacists
Unlocking AI's Potential in Managed Care: An Actionable Roadmap
The Fine Print of Affordability: What Employers and PBMs Need to Know About Cost-Shifting Strategies
Beyond the Buzzwords: What We Learned Bridging Pharmacy, Quality, AI, and Data Science to Improve Performance
Unlock Payer Market Research Opportunities with Cencora: What to Expect and How to Get Started
RWE Essentials Training Program - Provider & Health Plan Version
RWE Essentials Training Program - Life Sciences Version
Medical Benefits Training - Life Sciences Version
AMCP Training Programs - First Module Free
AMCP 2026 - Federal Legislative and Regulatory Update
From MFP to MFN — Price Controls, Politics & the Rebate Reckoning
Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care
The Future of Metabolic Health in Managed Care: Population Risk and Financial Impact
From Policy to Practice - PA/UM Trends, Evidence, and Coverage Alignment
Managed Care Approaches to Address Hard-to-Control Hypertension
Advancing Patient-Centered Care in Narcolepsy Type 1: Integrating the Latest Evidence, Guidelines, and Treatment Innovations
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice - Managed Care Insights into Hereditary Angioedema and Beta Thalassemia
[eLD 2] Research Podium Session - Leveraging Real-World Data to Advance Managed Care Pharmacy Practice
[eLD 1] Unpacking the Data: The Application and Interpretation of Real-World Evidence in GLP-1 Obesity Treatment

Pages